Eurofins Scientific SE
General ticker "ERFSF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $14.6B (TTM average)
Eurofins Scientific SE follows the US Stock Market performance with the rate: 20.2%.
Estimated limits based on current volatility of 2.2%: low 82.50$, high 86.27$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-29, amount 0.84$ (Y1.00%)
Short-term ERFSF quotes
Long-term ERFSF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €6,514.60MM | €6,951.00MM | €7,293.27MM |
| Operating Expenses | €5,275.60MM | €6,224.80MM | €6,474.97MM |
| Operating Income | €1,239.00MM | €726.20MM | €818.30MM |
| Non-Operating Income | €-815.70MM | €-171.60MM | €-164.54MM |
| Interest Expense | €129.40MM | €150.80MM | €165.94MM |
| Income(Loss) | €423.30MM | €554.60MM | €653.76MM |
| Taxes | €115.50MM | €149.10MM | €180.93MM |
| Net Income(Loss)* | €310.20MM | €406.40MM | €474.82MM |
| Stockholders Equity | €5,077.50MM | €5,339.00MM | €3,541.67MM |
| Inventory | €139.00MM | €141.90MM | €138.95MM |
| Assets | €10,888.60MM | €10,888.40MM | €10,980.89MM |
| Operating Cash Flow | €1,017.90MM | €1,318.90MM | €1,294.51MM |
| Capital expenditure | €550.10MM | €528.40MM | €759.72MM |
| Investing Cash Flow | €-681.10MM | €-846.50MM | €-1,086.59MM |
| Financing Cash Flow | €413.60MM | €-1,089.50MM | €13.00MM |
| Earnings Per Share** | €1.57 | €2.13 | €2.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.